Tag Archives: Drug Side Effects

Featured Stories

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

FDA backs previous stance on Pradaxa bleeding risks

Federal health officials have issued an update on its stance on the new blood thinner drug Pradaxa, indicating the risk of severe bleeding associated with the drug is no more significant than any other drugs available on the market for … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Elderly Dementia Linked to Anxiety, Insomnia Drugs

Elderly patients taking benzodiazepines or other similar anxiety or insomnia drugs are more likely to develop symptoms of dementia than those who avoid the drugs entirely. According to a WebMD.com report on a new study appearing in the journal, British … Continue reading

Posted in Pharmaceuticals | Tagged |

Doctors Petition FDA to Act on Opioid Painkillers

In response to growing opioid pain prescribing practice abuse, a group of doctors has petitioned the U.S. Food & Drug Administration (FDA) to take action on the powerful and powerfully addictive painkillers. Opioids are highly potent drugs approved for moderate … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged |

Watchdog Says FDA Needs Drug Safety Tracking Database

A leading public health advocacy group has suggested the Food and Drug Administration (FDA) approve a comprehensive system for tracking adverse reactions and dangerous side effects of prescription drugs once they reach the U.S. market. According to a HealthDay News … Continue reading

Posted in Pharmaceuticals | Tagged |

Report Finds FDA Post-Market Oversight of Drugs is Improving

A just-released report finds that the U.S. Food & Drug Administration’s (FDA) oversight of drugs is improving, says the agency. The report states that the FDA has strengthened the way in which it monitors post-approval drug safety—approved drugs receive equal … Continue reading

Posted in Pharmaceuticals | Tagged |

U.K. Regulator Warns of Tolvaptan Side Effects

A U.K. regulator just issued a warning over side effects linked to Tolvaptan. Side effects include serious neurological events. Tolvaptan is a selective vasopressin V2-receptor antagonist used for the treatment of adults diagnosed with hyponatremia, secondary to inappropriate anti-diuretic hormone … Continue reading

Posted in Pharmaceuticals | Tagged |

Study Finds Doctors Frequently Prescribe Drugs Off-Label

A new study finds that doctors are frequently prescribing medications for off-label uses The study looked at the off-label prescribing practices of primary care physicians in a Canadian network, said Science Daily. The report was published in Online First by … Continue reading

Posted in Pharmaceuticals | Tagged |

Drug Marketing Campaigns Obscure Side Effects

Although drug makers must indicate a drug’s adverse effects on its labeling, drug marketing campaigns obscure drug side effects. OpEdNews notes that 100,000 Americans die every year over complications from prescribed drugs; another 1.5 million people become ill or seriously … Continue reading

Posted in Legal News | Tagged |

Plavix – Aspirin Combo Linked to Higher Risk of Gastrointestinal bleeding

Taking low doses of aspirin along with the blood thinning drug < "http://www.yourlawyer.com/topics/overview/Plavix-Cerebral-Gastrointestinal-Bleeding-Hemorrhaging-Lawsuit-Lawyer">Plavix could increase the risk of gastrointestinal bleeding, according to a new study. According to a Reuters report, the authors of the study calculated that if 1,000 people … Continue reading

Posted in Legal News | Tagged , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.